Strategic approaches for early clinical trials in neurodegenerative diseases, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how early clinical trial strategies can support more informed development decisions in neurodegenerative diseases. The featured speakers will discuss study objectives and patient selection, incorporating the patient voice into early development and using biomarkers to guide decisions. Attendees will also explore approaches to addressing ethical and tolerability challenges in first-in-human studies.

TORONTO, Sept. 30, 2026 /PRNewswire/ -- Using patient-centric trial design and biomarker insights to support confident development decisions

Generating meaningful clinical insights as early as possible is a growing priority in neurodegenerative disease development. To support faster and more informed decision-making, sponsors are increasingly implementing innovative first-in-human study designs that integrate multiple objectives, streamline development pathways and enable earlier evaluation in patients. These approaches can also help address ethical and tolerability challenges that may limit traditional healthy volunteer studies.

This webinar will explore the opportunities and challenges associated with these strategies, highlighting examples from neurodegenerative disease therapeutics and discuss:

• Getting the basics right: Study objectives and population selection
• Bringing the patient voice into early development
• Biomarkers as decision-making tools in neurodegenerative development

Register for this webinar to learn how early clinical trial design, patient involvement and biomarker strategies can support more informed development decisions in neurodegeneration.

Join experts from ICON, Paula Kopschina Feltes, PhD, Senior Manager, Solutions Architect; and Matthias Mohse, Dipl-Psych, Director of Drug Development Services, for the live webinar on Wednesday, October 14, 2026, at 10am EDT (4pm CEST / EU-Central).

For more information, or to register for this event, visit Strategic approaches for early clinical trials in neurodegenerative diseases.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks